Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech graveyard
Biotech
Hookipa, having sold off vaccines to Gilead, opts to wind down
With its Poolbeg merger plans having bitten the dust and key assets sold to Gilead, Hookipa Pharma has decided it’s time to shut up shop completely.
James Waldron
Jul 21, 2025 3:15am
Oncternal sells cancer assets to mystery biotech, winds down ops
Jul 1, 2025 9:38am
CEO props up Aptose's finances to keep biotech from going bust
Jun 17, 2025 10:04am
Adios, iTeos: Biotech folds weeks after GSK TIGIT termination
May 28, 2025 9:19am
Vor Bio to wind down, laying off most staff
May 8, 2025 10:50am
Octagon shuts down after R&D challenges put it behind the 8 ball
Apr 29, 2025 7:40am
